Galectin Therapeutics
GALT
#8189
Rank
A$0.26 B
Marketcap
$4.19
Share price
-3.37%
Change (1 day)
40.89%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$0.99

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.02. In 2022 the company made an earnings per share (EPS) of -$1.00 a decrease over its 2021 EPS that were of -$0.80.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.99-1.2%
2022-$1.0025%
2021-$0.8030%
2020-$0.62-6.98%
2019-$0.6613.16%
2018-$0.59-22.45%
2017-$0.75-35.53%
2016-$1.17-13.64%
2015-$1.3611.39%
2014-$1.22-39.69%
2013-$2.0281.94%
2012-$1.11-32.08%
2011-$1.637.07%
2010-$1.52-17.5%
2009-$1.85150%
2008-$0.74-68%
2007-$2.31127.27%
2006-$1.02-52.17%
2005-$2.13-20.69%
2004-$2.6852.63%
2003-$1.76-13.64%
2002-$2.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$19.74 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.29-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA